Xencor Inc

Ticker XNCR

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

51-200 Employees
Based in Monrovia, California

Xencor is a clinical stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer.

Visit website

Social Media Links

REPORT RATINGS

4.8 / 5.0 (178)

Xencor Inc reports have an aggregate usefulness score of 4.8 based on 178 reviews.

Xencor Inc

Most Recent Annual Report

MOST RECENT 2022 Annual Report and Form 10K

View PDF View Form 10K (HTML)

Xencor Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Please fill out the form below and click "Place Order" to complete your order.